Detection and Treatment of Antibiotic-resistant Bacterial Carriage in a Surgical Intensive Care Unit: a 6-year Prospective Survey
Overview
Infectious Diseases
Nursing
Public Health
Affiliations
Objective: To describe, during a 6-year period, multidrug-resistant bacterial carriage in an intensive care unit (ICU).
Design: Prospective survey of 2235 ICU patients with methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E).
Setting: A surgical ICU in a tertiary-care teaching hospital.
Patients: All admitted patients.
Interventions: Nasal and rectal swabs were performed at admission and weekly thereafter. There was nasal application of mupirocin for MRSA carriers and selective digestive decontamination with local antibiotics for ESBL-E carriers.
Results: The swab compliance rate was 82% at admission and 51% during ICU stay. The rates of MRSA carriage or infection were 4.2 new cases per 100 admissions and 7.9 cases per 1000 patient-days during ICU stay. The rates of ESBL-E carriage or infection were 0.4 new case per 100 admissions and 3.9 cases per 1000 patient-days during ICU stay. Importation of MRSA increased significantly over time from 3.2 new cases per 100 admissions during the first 3 years to 5.5 during the last 3 years. The rate of ICU-acquired ESBLE decreased from 5.5 cases per 1000 patient-days during the first 3 years to 1.9 cases during the last 3 years. Nasal and digestive decontamination had low efficacy in eradicating carriage.
Conclusions: MRSA remained poorly controlled throughout the hospital and was not just a problem in the ICU. MRSA thus requires more effective measures throughout the hospital. ESBL-E was mainly an ICU pathogen and our approach resulted in a clear decrease in the rate of acquisition in the ICU over time.
Zhang H, Wang H, Tian F, Yang C, Zhao M, Ding Y Sci Rep. 2024; 14(1):24349.
PMID: 39420082 PMC: 11487172. DOI: 10.1038/s41598-024-75791-6.
Katkowska M, Garbacz K, Kwapisz E, Suligowska K, Kusiak A, Cichonska D Front Cell Infect Microbiol. 2023; 13:1265777.
PMID: 38035342 PMC: 10687414. DOI: 10.3389/fcimb.2023.1265777.
Mo Y, Oonsivilai M, Lim C, Niehus R, Cooper B PLoS Med. 2023; 20(6):e1004013.
PMID: 37319169 PMC: 10270346. DOI: 10.1371/journal.pmed.1004013.
Jung J, Park J, Yang H, Lim Y, Kim E, Lim C Antimicrob Resist Infect Control. 2023; 12(1):16.
PMID: 36869371 PMC: 9983515. DOI: 10.1186/s13756-023-01222-2.
Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH).
Rhim H, Won S, Kashefiolasl S, Brawanski N, Hattingen E, Berkefeld J Sci Rep. 2021; 11(1):8309.
PMID: 33859304 PMC: 8050277. DOI: 10.1038/s41598-021-87863-y.